Your browser doesn't support javascript.
loading
Molecular diagnostic tests to predict the risk of progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis patients.
Rossi, Francesca; Newsome, Scott D; Viscidi, Raphael.
  • Rossi F; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Electronic address: francesca12.rossi@uniroma1.it.
  • Newsome SD; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Viscidi R; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Mol Cell Probes ; 29(1): 54-62, 2015 Feb.
Article en En | MEDLINE | ID: mdl-25483260
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucoencefalopatía Multifocal Progresiva / Virus JC / Anticuerpos Monoclonales Humanizados / Esclerosis Múltiple Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Humans / Middle aged Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucoencefalopatía Multifocal Progresiva / Virus JC / Anticuerpos Monoclonales Humanizados / Esclerosis Múltiple Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Humans / Middle aged Idioma: En Año: 2015 Tipo del documento: Article